US Patent 7473694 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
Patent 7473694 was granted and assigned to Teijin Pharma on January, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Gen Unoki0
Hiroaki Makino0
Kenichiro Kataoka0
Mika Takakuwa0
Tomomi Kosugi0
Yuko Yamakoshi0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+438 characters)
Article
Patent abstract
A pyrazolopyrimidine derivative represented by formula (1) and pharmaceutically acceptable salt thereof exhibit excellent inhibitory activity against MAPKAP-K2. Accordingly, medicines containing this compound as an active ingredient are expected to be effective for treating diseases mediated by MAPKAP-K2 such as, for example, inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth.
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07473694 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof US Patent 7473694 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
Infobox
Patent Number
07473694
Patent Number
7473694
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07473694 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07473694
Date of patent
January 6, 2009
Patent application number
11377363
Date Filed
March 17, 2006
Patent primary examiner
Find more entities like US Patent 7473694 Pyrazolopyrimidine derivatives or pharmaceutically acceptable salts thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
